emodin has been researched along with Cancer of Liver in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (18.18) | 29.6817 |
| 2010's | 24 (54.55) | 24.3611 |
| 2020's | 12 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Brenes, R; Miller, DL; Nguyen, LMN; Rohde, ML | 1 |
| He, C; Shi, Y; Wang, Y; Yang, J; Zhao, H; Zhu, X | 1 |
| Chen, HL; Huang, Y; Lu, SF; Lu, Y; Wu, L; Xing, ML; Yang, FR; Yang, QW; Zhang, YT | 1 |
| Chen, X; Shen, G; Yin, J; Zhao, X | 1 |
| Gu, W; Peng, G; Qin, B; Shangwen, J; Tang, Y; Wang, Q; Wang, S; Wu, Y; Xu, J; Ye, ZJ; Zeng, Z | 1 |
| Huang, Y; Li, C; Liu, Y; Lu, P; Wu, W; Zhu, Z | 1 |
| Dai, X; Gao, R; Ning, H; Wang, M; Xu, H; Yu, B; Zhu, Y | 1 |
| Ali, M; Bhardwaj, SK; Chaudhary, A; Haque, R; Khan, A; Sinha, KK; Srivastava, A | 1 |
| Chen, X; Deng, H; Lai, Q; Leng, Y; Wang, H; Xiong, Z; Yang, M | 1 |
| Ma, C; Miao, W; Sun, R; Zhai, R | 1 |
| Bai, Y; Feng, H; Feng, J; Jia, W; Jiang, Y; Khan, H; Song, H; Yang, B; Yu, Z; Zaib, T | 1 |
| Alanazy, M; Dewdney, B; George, J; Gillman, R; Hebbard, L; Qiao, L; Roberts, A; Walker, S; Wankell, M | 1 |
| Guo, R; Jiang, Y; Liu, T; Lv, R; Ming, H; Tian, X; Wang, Q; Wei, H | 1 |
| Huang, LH; Li, Y; Pan, XP; Wang, C | 1 |
| Dong, H; Gao, M; Li, Q; Pang, Y; Tian, Y; Wang, J; Wu, G; Xu, H; Zhang, B; Zhang, C; Zhang, H | 1 |
| Li, N; Wang, C; You, S; Zhang, P | 1 |
| Dong, X; Fu, J; Leng, X; Liang, X; Ni, B; Ni, J; Yin, X; You, L | 1 |
| Kan, SY; Kang, H; Kim, BM; Kim, GH; Kim, JH; Kim, YS; Lee, YM; Lim, JH; Oh, TI; Shin, DH; Yim, WJ | 1 |
| Li, Y; Pan, X; Wang, C; Zhang, T; Zhu, L | 1 |
| Liu, JW; Sun, QF; Tang, Y; Wang, XW; Ye, ZJ; Zhou, DH; Zhou, RS | 1 |
| Gao, S; Jin, GZ; Li, C; Sun, S; Yang, WS | 1 |
| Bist, P; Hui, KM; Kumar, AP; Lim, LH; Manu, KA; Ong, TH; Perumal, E; Samy, RP; Sethi, G; Shanmugam, MK; Siveen, KS; Subramaniam, A | 1 |
| Chen, G; Hu, SM; Ke, SD; Qiu, H; Yu, SY; Zou, SQ | 1 |
| Ahn, KS; Hui, KM; Kumar, AP; Li, F; Loo, SY; Manu, KA; Park, JI; Perumal, E; Rajendran, P; Sethi, G; Shanmugam, MK; Siveen, KS; Subramaniam, A | 1 |
| Abbasi, T; Ahn, KS; Chen, L; Hui, KM; Kapoor, S; Kumar, AP; Li, F; Ong, TH; Perumal, E; Sethi, G; Shanmugam, MK; Subramaniam, A; Vali, S | 1 |
| Chen, Y; Zhang, T; Zhang, X; Zhang, Y | 1 |
| Deng, S; Gao, M; Guan, X; Liu, H; Lv, L; Tian, Y; Xu, H; Zhang, C | 1 |
| He, Y; Huang, J; Li, S; Liu, W; Shen, X; Suksamrarn, A; Wang, F; Wang, P; Yang, L; Zhang, G | 1 |
| Cui, Y; Liu, Q; Liu, X; Lu, P; Song, G; Zhu, D | 1 |
| Cao, Q; Chen, Y; Lin, W; Ling, C; Wang, C; Yin, H; Zhong, M | 1 |
| Guo, P; Qin, F; Wang, Q; Wang, Y; Xing, Y; Yan, Y; Zhang, J; Zhuang, J | 1 |
| Deng, S; Gao, D; Gao, M; Gao, X; Liu, H; Lv, L; Ma, C; Tian, Y; Wang, C; Xu, H; Zhang, C | 1 |
| Hsu, CM; Hsu, YA; Huang, SH; Shieh, FK; Tsai, FJ; Tsai, Y; Wan, L | 1 |
| Alisi, A; Balsano, C; Ghidinelli, M; Missale, G; Zerbini, A | 1 |
| Jeon, W; Jeon, YK; Nam, MJ | 1 |
| Lu, Y; Shan, W; Wang, T; Xiong, S; Yin, X | 1 |
| Goto, T; Nagashima, H; Nakamura, K | 1 |
| Gao, XG; Li, KZ; Lian, T; Liu, JB; Zhao, AZ | 1 |
| Chen, YY; Chiang, LC; Lin, CC; Shieh, DE; Yen, MH | 1 |
| Gu, LQ; Wang, XD; Wu, JY | 1 |
| Chung, MC; Lu, GD; Ong, CN; Shen, HM | 1 |
| Kim, HR; Kim, J; Kim, K; Kim, SJ; Lee, KH | 1 |
| Lin, SZ; Xu, XC | 1 |
1 review(s) available for emodin and Cancer of Liver
| Article | Year |
|---|---|
[Experimental advance of applying emodin for prevention and treatment of liver diseases].
Topics: Animals; Apoptosis; Cell Line, Tumor; Emodin; Humans; Liver Cirrhosis; Liver Neoplasms; Protective Agents | 2008 |
43 other study(ies) available for emodin and Cancer of Liver
| Article | Year |
|---|---|
HEPATOCELLULAR TOXICITY OF THE METABOLITE EMODIN PRODUCED BY THE COMMON BUCKTHORN (RHAMNUS CATHARTICA) IN GREEN FROG (LITHOBATES CLAMITANS) TADPOLES.
Topics: Animals; Carcinoma, Hepatocellular; Emodin; Fibrosis; Larva; Liver Neoplasms; Rana clamitans; Rhamnus | 2022 |
Automatic Segmentation of Magnetic Resonance Images of Severe Patients with Advanced Liver Cancer and the Molecular Mechanism of Emodin-Induced Apoptosis of HepG2 Cells under the Deep Learning.
Topics: Apoptosis; Deep Learning; Emodin; Hep G2 Cells; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging | 2022 |
Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Emodin; Glutamine; Liver Neoplasms; Mice; T-Lymphocytes, Regulatory; Tandem Mass Spectrometry; Transforming Growth Factor beta; Tumor Microenvironment | 2022 |
Emodin suppresses hepatocellular carcinoma growth by regulating macrophage polarization via microRNA-26a/transforming growth factor beta 1/protein kinase B.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Emodin; Humans; Liver Neoplasms; Macrophages; MicroRNAs; Proto-Oncogene Proteins c-akt; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin.
Topics: Autophagy; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Emodin; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2022 |
Emodin regulates the autophagy via the miR-371a-5p/PTEN axis to inhibit hepatic malignancy.
Topics: Autophagy; Cell Proliferation; Emodin; Humans; Liver Neoplasms; MicroRNAs; PTEN Phosphohydrolase | 2022 |
Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis.
Topics: Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Emodin; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Molecular Docking Simulation; Network Pharmacology; Survival Analysis | 2022 |
Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
Topics: Antineoplastic Agents; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Emodin; Humans; Liver Neoplasms; Oxides; Quercetin; Telomerase | 2023 |
Effect of emodin combined with cisplatin on the invasion and migration of HepG2 hepatoma cells.
Topics: Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Emodin; Epithelial-Mesenchymal Transition; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Vimentin | 2023 |
Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Drug Synergism; Emodin; Female; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2020 |
Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Emodin; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Invasiveness; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays | 2020 |
The effects of fructose and metabolic inhibition on hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Databases, Factual; Emodin; Energy Metabolism; Fructose; Humans; Liver Neoplasms; Mice; Survival Rate | 2020 |
RETRACTED: Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Emodin; Glucosides; Growth Inhibitors; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-pim-1; Xenograft Model Antitumor Assays | 2017 |
Physcion induces apoptosis through triggering endoplasmic reticulum stress in hepatocellular carcinoma.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Emodin; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
N-acetylaminogalactosyl-decorated biodegradable PLGA-TPGS copolymer nanoparticles containing emodin for the active targeting therapy of liver cancer.
Topics: Apoptosis; Biological Transport; Drug Carriers; Emodin; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Targeted Therapy; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2018 |
Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Emodin; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Immunohistochemistry; Liver Neoplasms; Mice; MicroRNAs; Pancreatic Neoplasms; Protein Kinase Inhibitors | 2018 |
Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase‑dependent pathway.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Emodin; Gene Expression Regulation, Enzymologic; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Protein Kinase Inhibitors; Reactive Oxygen Species; Tumor Cells, Cultured | 2018 |
Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Synergism; Emodin; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; Sterol Regulatory Element Binding Protein 2; Xenograft Model Antitumor Assays | 2018 |
RETRACTED: Protective autophagy induced by physcion suppresses hepatocellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis.
Topics: Animals; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Emodin; Humans; Janus Kinase 2; Liver Neoplasms; Male; Mice, Inbred BALB C; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2018 |
Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Computational Biology; Emodin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Protein Interaction Mapping; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Receptors, Purinergic P2; Receptors, Somatostatin; Signal Transduction; Software; Transcriptome | 2019 |
β-Dihydroartemisinin-Emodin Promotes Apoptosis by Activating Extrinsic and Intrinsic Pathways in Human Liver Cancer Cells.
Topics: Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Emodin; Hep G2 Cells; Humans; Ki-67 Antigen; Liver Neoplasms; Survivin; Wound Healing | 2019 |
Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Emodin; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; NF-kappa B; Receptors, CXCR4; RNA, Messenger; Signal Transduction; Wound Healing | 2013 |
Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Emodin; Endonucleases; Fibroblast Growth Factor 7; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Organoplatinum Compounds; Oxaliplatin; Phosphorylation; Receptor, Fibroblast Growth Factor, Type 2; RNA Interference; Signal Transduction; Transfection | 2013 |
An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Emodin; Humans; Liver Neoplasms; Reactive Oxygen Species; Receptors, Death Domain; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP | 2013 |
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Emodin; ErbB Receptors; Female; Hep G2 Cells; Humans; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Liver Neoplasms; Male; Mice; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Inhibitory effect of emodin on human hepatoma cell line SMMC-7721 and its mechanism.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Emodin; Humans; Liver Neoplasms; Microscopy, Electron | 2015 |
A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Emodin; Humans; Lactic Acid; Liver Neoplasms; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley | 2016 |
Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cell Proliferation; Emodin; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoprecipitation; Interferon-alpha; Interferon-beta; Janus Kinases; Liver Neoplasms; Mice; Mice, Nude; Phosphorylation; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis.
Topics: Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Emodin; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Hepatoblastoma; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction | 2016 |
Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Emodin; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2016 |
Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells.
Topics: Adenylate Kinase; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Down-Regulation; Emodin; Epithelial-Mesenchymal Transition; Glucosides; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Invasiveness; Reactive Oxygen Species; Signal Transduction; Sp1 Transcription Factor | 2016 |
Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Emodin; Fluorescent Dyes; Heparin; Humans; Liver Neoplasms; Male; Mice; Nanoparticles; Particle Size; Surface Properties; Vitamin E | 2016 |
Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Emodin; Gene Expression; Gene Expression Profiling; Hep G2 Cells; Humans; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Protein Kinase Inhibitors | 2010 |
Hepatitis C virus and alcohol: same mitotic targets but different signaling pathways.
Topics: Aurora Kinase A; Aurora Kinases; Biopsy; Carcinoma, Hepatocellular; Central Nervous System Depressants; Cyclin B1; Drug Interactions; Emodin; Ethanol; Hep G2 Cells; Hepatitis C, Chronic; Humans; In Vitro Techniques; Liver Diseases, Alcoholic; Liver Neoplasms; Mitosis; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Tubulin | 2011 |
Apoptosis by aloe-emodin is mediated through down-regulation of calpain-2 and ubiquitin-protein ligase E3A in human hepatoma Huh-7 cells.
Topics: Aloe; Antineoplastic Agents, Phytogenic; Apoptosis; Calpain; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; Down-Regulation; Emodin; Humans; Liver Neoplasms; Ubiquitin-Protein Ligases | 2012 |
Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Emodin; Female; Humans; Leukemia L1210; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred ICR; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Random Allocation; Tissue Distribution; Transferrin; Vitamin E | 2012 |
Rubratoxin B induced the secretion of hepatic injury-related colony stimulating factors in human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Emodin; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Hepatocytes; Humans; Interleukin-8; Liver Neoplasms; Macrophage Colony-Stimulating Factor; Mycotoxins | 2003 |
[Apoptosis of human hepatoma HepG2 cells induced by emodin in vitro].
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Division; Emodin; Enzyme Inhibitors; Flow Cytometry; Humans; Liver Neoplasms; Tumor Cells, Cultured | 2003 |
Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Emodin; fas Receptor; Humans; Liver Neoplasms; Signal Transduction; Tumor Suppressor Protein p53 | 2004 |
Aloe vera (Aloe barbadensis, Aloe capensis).
Topics: Aloe; Apoptosis; Emodin; Humans; Liver Neoplasms | 2007 |
Apoptosis-inducing activity of new pyrazole emodin derivatives in human hepatocellular carcinoma HepG2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Emodin; Enzyme Activation; Formazans; Humans; Liver Neoplasms; Molecular Structure; Poly(ADP-ribose) Polymerases; Tetrazolium Salts; Time Factors | 2007 |
Critical role of oxidative stress and sustained JNK activation in aloe-emodin-mediated apoptotic cell death in human hepatoma cells.
Topics: Aloe; Apoptosis; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Emodin; Glutathione; Glutathione Disulfide; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Plant Extracts | 2007 |
Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death.
Topics: Apoptosis; Carcinoma, Hepatocellular; Casein Kinase II; Cytoplasmic Granules; Cytotoxicity, Immunologic; Emodin; Fas Ligand Protein; Humans; Killer Cells, Natural; Liver Neoplasms; Protein Kinase Inhibitors; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2008 |